Login
Register

Home

Trainings

Fusion Blog

EBS Blog

Authors

CONTACT US

Fusion Blog
  • Register

Oracle Gold Partners, our very popular training packages, training schedule is listed here
Designed by Five Star Rated Oracle Press Authors & Oracle ACE's.

webinar new

Search Courses

Writing every line to a journal is not always possible.Instead of writing many lines of journal entries,a journal can be imported from the Spreadsheet directly through ADFDI.

The following example will guide you better,step by step -

  • From Task Bar choose Create Journal in Spreadsheet

 

  • Connect Spreadsheet to the Instance Access

  • Fill in Details regarding the Ledger and Journal

  • Write the Journal Lines

  • Enter Journal Lines

  • Post Journal - In order to post Journal ,use Submit Journal

  • The final step - Confirmation Message that the Journal was posted

 

 

 


rochelle Cunningham

Comments   

0 #1 tcsgroupd 2022-09-26 18:34
fevipiprant (inn; code name qaw039) is a drug being developed by novartis which acts as a selective, orally available antagonist of the prostaglandin d2 receptor 2 (dp2 or crth2).

as of 2016, it is in phase iii clinical trials for the treatment of asthma.

on monday, december 16, 2019, switzerland-bas ed novartis officially announced that it was jettisoning fevipiprant from its development program, given that the medicine has failed in two additional clinical trials in patients with moderate-to-sev ere asthma. the firm said that it had hoped fevipiprant would be a billion-dollar- selling asthma drug.
Quote

Add comment


Security code
Refresh

About the Author

rochelle Cunningham

More articles from this author

Search Trainings

Fully verifiable testimonials

Apps2Fusion - Event List

<<  May 2024  >>
 Mon  Tue  Wed  Thu  Fri  Sat  Sun 
    1  2  3  4  5
  6  7  8  9101112
13141516171819
20212223242526
2728293031  

Enquire For Training

Fusion Training Packages

Get Email Updates


Powered by Google FeedBurner